historical comparison of survivals why not but only under certain conditions
暂无分享,去创建一个
[1] F. Angrilli,et al. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Giorgi,et al. A log‐rank‐type test to compare net survival distributions , 2016, Biometrics.
[3] T. Hakulinen,et al. Choosing the net survival method for cancer survival estimation. , 2015, European Journal of Cancer.
[4] F. Bray,et al. A comparison of relative and cause‐specific survival by cancer site, age and time since diagnosis , 2014, International journal of cancer.
[5] Eric J Feuer,et al. Secular trends in colon and rectal cancer relative survival. , 2013, Journal of the National Cancer Institute.
[6] Janez Stare,et al. On Estimation in Relative Survival , 2012, Biometrics.
[7] T. Blakely,et al. Measuring cancer survival in populations: relative survival vs cancer-specific survival. , 2010, International journal of epidemiology.
[8] P. Gobbi,et al. Long Term Follow-up Analysis of HD9601 Trial Comparing ABVD Vs Stanford V Vs MOPPABVCAD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma. A Study from the Intergruppo Italiano Linfomi (IIL) , 2008 .
[9] David R. Jones,et al. Relative survival: what can cardiovascular disease learn from cancer? , 2008, European heart journal.
[10] M. Davies,et al. Clinicians didn't reliably distinguish between different causes of cardiac death using case histories. , 2006, Journal of clinical epidemiology.
[11] P. Gobbi,et al. Unlike ABVD and MOPPEBVCAD, Stanford V chemotherapy does not tollerate the combination with a reduced and conditioned radiotherapy for the treatment of advanced Hodgkin Lymphoma , 2006 .
[12] P. Dickman,et al. Estimating and modelling relative survival , 2004 .
[13] E. Feuer,et al. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. , 2000, Statistics in medicine.
[14] E J Topol,et al. Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.
[15] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[16] F. Wilner,et al. Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1975, Michigan medicine.
[17] F. Ederer,et al. The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.